Showing results for Diabetes
An evolutionary cul-de-sac: Study suggests most humans are vulnerable to Type 2 diabetes
IU School of Medicine | Nov 02, 2020
IU researchers in nationwide network to study rare form of diabetes
IU School of Medicine | Oct 06, 2020
IU School of Medicine leading national study to treat diabetic foot wounds, decrease amputation rates
IU School of Medicine | Jul 24, 2020
Diabetes center recognizes scientists for promising projects
IU School of Medicine | Jun 18, 2020
Evans-Molina named director of diabetes research center
INDIANAPOLIS—Carmella Evans-Molina, MD, PhD, has been appointed director of the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine. Evans-Molina is the center’s second appointed director since it received designation from the National Institutes of Health in 2015. The center’s mission is to bring cutting-edge research tools to diabetes investigators at […]
IU School of Medicine | Oct 08, 2019
Funding to help researchers study link between high blood sugar, cancer
It is well understood that people with diabetes have an increased risk for a number of other health complications—including cancer. Last year, when Indiana University School of Medicine researchers demonstrated that inflammation can increase risk for leukemia, they wondered if it was also the culprit that placed people with diabetes at a higher risk for […]
IU School of Medicine | Jun 14, 2019
Study based at Indiana University School of Medicine finds improvements in insulin production wane after treatment stops in adults with early type 2 diabetes
A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]
Christina Griffiths | Jun 10, 2019
Immunotherapy delays Type 1 diabetes diagnosis in people at high risk
Presented on June 9 in San Francisco at the 2019 American Diabetes Association’s 79th Scientific Sessions and published in the New England Journal of Medicine, findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study show a drug that targets the immune system can delay Type 1 diabetes a median of 2 years in children and adults at […]
IU School of Medicine | Jun 09, 2019
IU announces progress toward its Precision Health Grand Challenge: cancers it aims to cure, diseases it is working to prevent
Indiana University researchers and physicians announced progress toward their bold goals of developing cures and preventive treatments for devastating diseases prevalent among Indiana residents.
IU School of Medicine | Aug 06, 2018
IU School of Medicine researcher awarded $1.9 million grant to study vision-threatening condition
Indiana University School of Medicine was recently awarded a five-year, $1.9 million grant by to study diabetic retinopathy, a long-term, vision-threatening complication of diabetes.
IU School of Medicine | Oct 24, 2017